These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7521377

  • 1. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M, Carreño V.
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines C, Herrero M, Carreño V.
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [Abstract] [Full Text] [Related]

  • 3. Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.
    Pawlotsky JM, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L, Roudot-Thoraval F, Duvoux C, Douvin C, Mallat A.
    J Med Virol; 1995 Nov; 47(3):285-91. PubMed ID: 8551282
    [Abstract] [Full Text] [Related]

  • 4. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C.
    Nagayama R, Miyake K, Tsuda F, Okamoto H.
    J Med Virol; 1994 Mar; 42(3):311-7. PubMed ID: 7516423
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F, Abate ML, Mondardini A, Baldi M, Leandro G, Lombardi S, Wolfe L, Ryff JC, Verme G, Brunetto MR.
    J Viral Hepat; 1995 Mar; 2(4):171-4. PubMed ID: 7489343
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
    Saracco G, Abate ML, Baldi M, Calvo PL, Manzini P, Brunetto MR, Oliveri F, Kuo G, Chien D, Houghton M.
    Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
    [Abstract] [Full Text] [Related]

  • 8. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF, Elste C, Dienes HP, Michel G, Braun HB, Meyer zum Büschenfelde KH, Gerken G.
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A, Sodeyama T, Matsumoto A, Tanaka E.
    J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus RNA and anti-N14 antibody levels during interferon alpha therapy for chronic hepatitis C.
    Oketani M, Tanaka K, Sho Y, Maeda E, Miyazaki H, Arima T.
    Intern Med; 1994 Oct; 33(10):588-92. PubMed ID: 7530068
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short and long-term effects of interferon on serum markers of hepatitis C virus replication.
    Yatsuhashi H, Inoue O, Inokuchi K, Koga M, Nagataki S, Cha TA, Irvine B, Stempien M, Kolberg J, Urdea MS.
    J Gastroenterol Hepatol; 1993 Oct; 8(1):1-6. PubMed ID: 8382537
    [Abstract] [Full Text] [Related]

  • 18. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia.
    L'Abbate A, Cutrupi S, Rognetta M, Fabiano C, Craxi A.
    Clin Exp Immunol; 1993 Nov; 94(2):313-6. PubMed ID: 7693384
    [Abstract] [Full Text] [Related]

  • 19. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
    Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Cristiano K, Feinstone SM, Hoofnagle JH.
    Ann Intern Med; 1991 Nov 01; 115(9):700-4. PubMed ID: 1656828
    [Abstract] [Full Text] [Related]

  • 20. HCV replication in mononuclear cells stimulates anti-HCV-secreting B cells and reflects nonresponsiveness to interferon-alpha.
    Löhr HF, Goergen B, Meyer zum Büschenfelde KH, Gerken G.
    J Med Virol; 1995 Aug 01; 46(4):314-20. PubMed ID: 7595407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.